San Daniele del Friuli, Udine, Italy—March 2, 2016
Lima Corporate is pleased to announce that they have entered into an Innovation Alliance Agreement with the Hospital for Special Surgery (HSS), a global leader of care delivery and innovation in orthopedics and rheumatology. "This alliance fosters the overall relationship between Lima Corporate and HSS and will focus on key areas from new product development to a discovery lab to cultivate innovation and new technologies geared to improving the lives of patients everywhere," said Leonard Achan, HSS – Chief Innovation Officer.
HSS and Lima are already active with a number of new product development projects. In particular, Lima and HSS have started to develop an innovative total elbow prosthesis which combines technology from an HSS patent together with Trabecular Titanium, a proprietary material produced by Lima. The two parties are also collaborating on an advanced acetabular cup design, a project that includes basic research testing aimed to define an optimal implant design. Under this agreement, the areas of product development will continue to expand.
The discovery lab will permit both parties to engage in innovative research areas, new prostheses design as well as expanding to other joints based on the clinical need from the HSS surgeon experience, aimed to continue to develop innovative solutions in the field of Orthopedics. Lima Corporate has been one of the pioneers in orthopedics using 3D printing first for the production of standard products, then for patient specific solutions, which lead to the launch of ProMade, a dedicated division within Lima Corporate. The collaboration in this area will allow surgeons around the world who use ProMade to have their case review performed by the experts at HSS prior to finalizing the patient specific model.
"Innovation has been key to HSS excellence for more than a century, and we’re excited to further extend the reach and impact of HSS by leveraging our knowledge and clinical expertise with the capabilities of Lima," said Louis Shapiro, President and CEO of HSS. "This alliance is an important step for the future of HSS as we build upon our tradition of excellence and musculoskeletal specialization to create value-based and patient-centered healthcare solutions that include new products and services for a global market."
"HSS is a highly specialized institution that delivers world-renowned care, and I am honored that HSS has chosen Lima Corporate as a Strategic partner. Our R&D and Manufacturing capabilities will be available to HSS to help advance innovative solutions developed together. This is a first time partnership of this magnitude for Lima Corporate and will strive to progress treatments and techniques for patients around the world," said Luigi Ferrari, CEO of Lima Corporate.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.